Presentation_1_S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.PPT by Ji-Sook Lee (632672)

“…The surface TLR4 expression increased after exposure to S100A8 and S100A9 although total TLR4 expression decreased. …”

Comparison of baseline characteristics stratified by the occurrence of ISR > 50%. by Jae-Chan Ryu (2850581)

Subjects:

Baseline characteristics of patients with intracranial stent insertion. by Jae-Chan Ryu (2850581)

Subjects:

Binary and ordinal logistic regression analysis of predictors for the occurrence of ISR > 50%. by Jae-Chan Ryu (2850581)

Subjects:

Water-Assisted Proton Transport in Confined Nanochannels by Xinyou Ma (3697816)

“…Herein, excess proton confinement effects are computationally investigated for sub-2 nm hydrophobic nanopores by varying the diameters (<i>d</i> = 0.81, 0.95, 1.09, 1.22, 1.36, 1.63, and 1.90 nm), lengths (<i>l</i> ∼3 and ∼5 nm), curvature, and chirality of cylindrical carbon nanotube (CNT) nanopores. …”

Water-Assisted Proton Transport in Confined Nanochannels by Xinyou Ma (3697816)

“…Herein, excess proton confinement effects are computationally investigated for sub-2 nm hydrophobic nanopores by varying the diameters (<i>d</i> = 0.81, 0.95, 1.09, 1.22, 1.36, 1.63, and 1.90 nm), lengths (<i>l</i> ∼3 and ∼5 nm), curvature, and chirality of cylindrical carbon nanotube (CNT) nanopores. …”

Water-Assisted Proton Transport in Confined Nanochannels by Xinyou Ma (3697816)

“…Herein, excess proton confinement effects are computationally investigated for sub-2 nm hydrophobic nanopores by varying the diameters (<i>d</i> = 0.81, 0.95, 1.09, 1.22, 1.36, 1.63, and 1.90 nm), lengths (<i>l</i> ∼3 and ∼5 nm), curvature, and chirality of cylindrical carbon nanotube (CNT) nanopores. …”

Percentage drug content of MF-CS-NPs stored at 25 ± 2°C, 65% ± 5% RH after 0–6 months storage. by Alireza Latifi (14593561)

Spectra of the light sources used in this study. by Kaoru Okamoto Yoshiyama (14526661)

Mean dry weight of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean fresh weight of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean proline contents of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Mean mitotic index of mung bean root tips under Cd treatments alone and priming with phytohormones and proline prior to Cd stress. by Meher Hassan (11502144)

Mean SOD activities of mung bean grown under Cd and pretreatments of GA₃, SA and proline prior to Cd. by Meher Hassan (11502144)

Effects of 254- and 222-UVC exposure on <i>C</i>. <i>elegans</i> hatching rate. by Kaoru Okamoto Yoshiyama (14526661)

Effects of 254- or 222-UVC exposure on <i>C</i>. <i>elegans</i> motility. by Kaoru Okamoto Yoshiyama (14526661)

Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group) by Enrica Seravalli (4862974)

“…The lowest mean dose for organs at risk is obtained with proton therapy. …”

Discovery of Novel Imidazo[4,5‑<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Inte... by Xuewu Liang (3071676)

“…Especially, lead compound <b>8l</b> showed potent inhibitory activities against interferon-stimulated genes (IC₅₀: 3.3 nM) and NF-κB pathways (IC₅₀: 150.7 nM) and decreased the release of various proinflammatory factors at the nanomolar level, including IL-6, IL-8, IL-1β, TNF-α, IL-12, and IFN-γ. …”

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…However, this disadvantage can be transformed with a meticulous design into a functional drug delivery platform. Here, we report <b>Nano-CC1-Acl</b>, a nanoaggregate engineered for targeted anticancer activity. …”

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…However, this disadvantage can be transformed with a meticulous design into a functional drug delivery platform. Here, we report <b>Nano-CC1-Acl</b>, a nanoaggregate engineered for targeted anticancer activity. …”